43 studies found for:
" May 21, 2008":" June 20, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Terminated |
Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
|
||||
| 22 | Completed |
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
|
||||
| 23 | Recruiting |
Smoking Cessation Using Motivational Therapy and Varenicline
|
||||
| 24 | Completed |
Durability of Nevirapine-Based Antiretroviral Regimen
|
||||
| 25 | Active, not recruiting |
Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
|
||||
| 26 | Unknown † |
The Detection of Drug-Resistant HIV-1 in Taiwan
|
||||
| 27 | Withdrawn |
A Long Term Safety Study of Apricitabine in HIV-infected Patients
|
||||
| 28 | Completed |
Kaletra-isentress Treatment Evaluation
|
||||
| 29 | Completed |
Integrated Treatment of Marijuana Abuse for HIV+ Youth
|
||||
| 30 | Unknown † |
Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
|
||||
| 31 | Completed |
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
|
||||
| 32 | Withdrawn |
Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
|
||||
| 33 | Completed |
Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
|
||||
| 34 | Withdrawn |
Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort
|
||||
| 35 | Active, not recruiting |
Neurocognitive Assessment in Youth Initiating HAART
|
||||
| 36 | Completed |
Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
|
||||
| 37 | Enrolling by invitation |
Age-17 Follow-up of Home Visiting Intervention
|
||||
| 38 | Recruiting |
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
|
||||
| 39 | Completed |
Linkage to Care - Part I
|
||||
| 40 | Unknown † |
TDM of Generic Lopinavir/Ritonavir 200/50 mg
|
† Indicates status has not been verified in more than two years

